A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction

Increasing evidence indicates that decreased brain blood flow, increased reactive oxygen species (ROS) production, and proinflammatory mechanisms accelerate neurodegenerative disease progression such as that seen in vascular contributions to cognitive impairment and dementia (VCID) and Alzheimer’s d...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Pharmacol Exp Ther
Auteurs principaux: Hay, Meredith, Polt, Robin, Heien, Michael L., Vanderah, Todd W., Largent-Milnes, Tally M., Rodgers, Kathleen, Falk, Torsten, Bartlett, Mitchell J., Doyle, Kristian P., Konhilas, John P.
Format: Artigo
Langue:Inglês
Publié: The American Society for Pharmacology and Experimental Therapeutics 2019
Sujets:
Drug Discovery and Translational Medicine
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6413771/
https://ncbi.nlm.nih.gov/pubmed/30709867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.118.254854
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires